Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., . . . Payami, H. (2017). Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Movement disorders, 32(5), 739-749. https://doi.org/10.1002/mds.26942
Chicago Style (17th ed.) CitationHill‐Burns, Erin M., et al. "Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome." Movement Disorders 32, no. 5 (2017): 739-749. https://doi.org/10.1002/mds.26942.
MLA (9th ed.) CitationHill‐Burns, Erin M., et al. "Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome." Movement Disorders, vol. 32, no. 5, 2017, pp. 739-749, https://doi.org/10.1002/mds.26942.